Please use this identifier to cite or link to this item:
Title: Corticosteroids and community-acquired pneumonia
Authors: Solé Violán, Jorge
Marcos y Ramos, Alberto
Aspa Marco, Javier
Rodríguez de Castro, Felipe 
Issue Date: 2003
Publisher: 1068-0640
Journal: Clinical Pulmonary Medicine 
Abstract: In pneumonia, the initiation, maintenance, and resolution of inflammation depend on the expression of a complex network of proinflammatory and anti-inflammatory cytokines. A balance between those cytokines is necessary to protect the host from an overzealous inflammatory response with potential harmful effects. The outcome of patients with pulmonary infection depends upon this fine tuning of inflammation. The role of corticosteroids in the treatment of patients with community-acquired pneumonia is unknown, and there is no evidence to support its use in these patients. However, there appears to be a potential role for corticosteroids in some related conditions, such as severe sepsis, adult respiratory distress syndrome, and bronchiolitis obliterans-organizing pneumonia. Further studies are needed to assess not only which patients might benefit from glucocorticoids but also the optimal dose and duration of treatment.
ISSN: 1068-0640
DOI: 10.1097/01.cpm.0000087611.74932.d2
Source: Clinical Pulmonary Medicine[ISSN 1068-0640],v. 10, p. 255-262
Appears in Collections:Reseña
Show full item record


checked on Feb 28, 2021

Page view(s)

checked on Mar 6, 2021

Google ScholarTM




Export metadata

Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.